Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?| Positive | ||
| Negative | ||
| Uncertain | ||
| Constraining | ||
| Legalese | ||
| Litigous | ||
| Readability |
H.S. junior Avg
|
|
New words:
accommodate, accrual, adult, aforementioned, aim, Akebia, ASH, begun, bevicizumab, billed, BioPharma, Biostage, Blaine, box, bringing, budget, cap, category, CCPA, characterized, closure, CMO, constraint, context, destruction, developmental, display, distributor, doublet, drove, durable, Eastern, ESMO, ESPP, evidenced, exceeded, explored, fluid, forecasted, furlough, Fusion, GDPR, grantor, Hochberg, Homology, HR, indefinitely, invasive, KATHERINE, lag, landscape, Lastly, McKee, MEN, Menarini, mentioned, MIT, monotherapy, municipal, neoadjuvant, network, Nonemployee, OBT, outsource, pattern, payroll, pension, play, predominant, pretreated, privacy, properly, Province, refractory, reliant, residual, screening, SGO, shipment, shut, shutdown, Sloan, store, strive, swap, tail, tool, trend, turn, unconditionally, unexercised, unrelated, VBI, vialed, week
Removed:
aggregation, allocable, assignee, Biosimilarity, Boehringer, BSP, calculating, Carbogen, composition, considerably, david, deduction, Demonstration, depict, diminish, doubt, employer, enforcement, estimating, estimation, excluding, exploit, flat, Formal, Ingelheim, johnston, jointly, lack, LIFO, Michigan, mix, mode, multiplied, nonproprietary, occupied, outlicense, persuasive, Pharmacology, PHS, posted, procured, Protein, reliance, rest, resume, retail, SAFC, Simplifying, Subtopic, territory, tolerated, transferability, Unanticipated, website
Filing tables
Filing exhibits
Related press release
Associated IMGN transcripts
IMGN similar filings
Filing view
External links
EXHIBIT 23
Consent of Independent Registered Public Accounting Firm
We consent to the incorporation by reference in the following Registration Statements (Form S-8 Nos. 333-138713, 333-147738, 333-155540, 333-170788, 333-185086, 333-200432, 333-215196, 333-225281, 333-225860 and 333-219718 and Form S-3 Nos. 333-216438 and 333-223507) of ImmunoGen Inc. of our reports dated March 1, 2019, with respect to the consolidated financial statements of ImmunoGen Inc. and the effectiveness of internal control over financial reporting of ImmunoGen Inc. included in this Annual Report (Form 10-K) of ImmunoGen Inc. for the year ended December 31, 2018.
/s/ Ernst & Young LLP
Boston, Massachusetts
March 1, 2019